151 related articles for article (PubMed ID: 8384822)
1. Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium.
Lamp KC; Rybak MJ
Antimicrob Agents Chemother; 1993 Mar; 37(3):605-9. PubMed ID: 8384822
[TBL] [Abstract][Full Text] [Related]
2. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
[TBL] [Abstract][Full Text] [Related]
3. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
4. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
Stratton CW; Weeks LS
Diagn Microbiol Infect Dis; 1990; 13(3):245-52. PubMed ID: 2166634
[TBL] [Abstract][Full Text] [Related]
5. Influence of protein binding under controlled conditions on the bactericidal activity of daptomycin in an in vitro pharmacodynamic model.
Cha R; Rybak MJ
J Antimicrob Chemother; 2004 Jul; 54(1):259-62. PubMed ID: 15150172
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.
Bailey EM; Rybak MJ; Kaatz GW
Antimicrob Agents Chemother; 1991 Jun; 35(6):1089-92. PubMed ID: 1834010
[TBL] [Abstract][Full Text] [Related]
8. In-vitro modelling of the bactericidal activity of teicoplanin versus flucloxacillin as used in surgical prophylaxis, against Staphylococcus aureus.
Steer JA; Hill GB; Robbins MJ; Newton JC; Wilson AP
J Antimicrob Chemother; 1997 Apr; 39(4):477-81. PubMed ID: 9145820
[TBL] [Abstract][Full Text] [Related]
9. In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.
Lamp KC; Rybak MJ; Bailey EM; Kaatz GW
Antimicrob Agents Chemother; 1992 Dec; 36(12):2709-14. PubMed ID: 1336344
[TBL] [Abstract][Full Text] [Related]
10. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
Bowker KE; Noel AR; MacGowan AP
J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041
[TBL] [Abstract][Full Text] [Related]
11. Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.
Fuchs PC; Barry AL; Brown SD
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):51-8. PubMed ID: 11025184
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.
Hanberger H; Nilsson LE; Maller R; Isaksson B
Antimicrob Agents Chemother; 1991 Sep; 35(9):1710-6. PubMed ID: 1659305
[TBL] [Abstract][Full Text] [Related]
14. Protein binding and serum bactericidal activities of vancomycin and teicoplanin.
Dykhuizen RS; Harvey G; Stephenson N; Nathwani D; Gould IM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1842-7. PubMed ID: 7486929
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens.
Petersen PJ; Bradford PA; Weiss WJ; Murphy TM; Sum PE; Projan SJ
Antimicrob Agents Chemother; 2002 Aug; 46(8):2595-601. PubMed ID: 12121938
[TBL] [Abstract][Full Text] [Related]
16. Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureus.
Stanley D; McGrath BJ; Lamp KC; Rybak MJ
Pharmacotherapy; 1994; 14(1):35-9. PubMed ID: 8159599
[TBL] [Abstract][Full Text] [Related]
17. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.
Voorn GP; Kuyvenhoven J; Goessens WH; Schmal-Bauer WC; Broeders PH; Thompson J; Michel MF
Antimicrob Agents Chemother; 1994 Mar; 38(3):487-93. PubMed ID: 8203842
[TBL] [Abstract][Full Text] [Related]
18. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.
Vaudaux P; Francois P; Berger-Bächi B; Lew DP
J Antimicrob Chemother; 2001 Feb; 47(2):163-70. PubMed ID: 11157900
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
[TBL] [Abstract][Full Text] [Related]
20. The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species.
Richter SS; Kealey DE; Murray CT; Heilmann KP; Coffman SL; Doern GV
J Antimicrob Chemother; 2003 Jul; 52(1):123-7. PubMed ID: 12805265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
